These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26513759)

  • 1. Synthesis and immunodetection of 6-O-methyl-phosphoramidyl-α-D-galactose: a Campylobacter jejuni antigenic determinant.
    Jiao Y; Ma Z; Ewing CP; Guerry P; Monteiro MA
    Carbohydr Res; 2015 Dec; 418():9-12. PubMed ID: 26513759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The design of a capsule polysaccharide conjugate vaccine against Campylobacter jejuni serotype HS15.
    Bertolo L; Ewing CP; Maue A; Poly F; Guerry P; Monteiro MA
    Carbohydr Res; 2013 Jan; 366():45-9. PubMed ID: 23261782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase-Variable Changes in the Position of
    Pequegnat B; Laird RM; Ewing CP; Hill CL; Omari E; Poly F; Monteiro MA; Guerry P
    J Bacteriol; 2017 Jul; 199(14):. PubMed ID: 28461446
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of the Campylobacter jejuni 81-176 Strain Capsular Polysaccharide Repeating Unit Reveals the Absolute Configuration of its O-Methyl Phosphoramidate Motif.
    Thota VN; Ferguson MJ; Sweeney RP; Lowary TL
    Angew Chem Int Ed Engl; 2018 Nov; 57(47):15592-15596. PubMed ID: 30280458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campylobacter polysaccharide capsules: virulence and vaccines.
    Guerry P; Poly F; Riddle M; Maue AC; Chen YH; Monteiro MA
    Front Cell Infect Microbiol; 2012; 2():7. PubMed ID: 22919599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies.
    Poly F; Read TD; Chen YH; Monteiro MA; Serichantalergs O; Pootong P; Bodhidatta L; Mason CJ; Rockabrand D; Baqar S; Porter CK; Tribble D; Darsley M; Guerry P
    Infect Immun; 2008 Dec; 76(12):5655-67. PubMed ID: 18809665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Immunogenicity and Protective Efficacy of a
    Ramakrishnan A; Schumack NM; Gariepy CL; Eggleston H; Nunez G; Espinoza N; Nieto M; Castillo R; Rojas J; McCoy AJ; Beck Z; Matyas GR; Alving CR; Guerry P; Poly F; Laird RM
    mSphere; 2019 May; 4(3):. PubMed ID: 31043512
    [No Abstract]   [Full Text] [Related]  

  • 8. Commonality and biosynthesis of the O-methyl phosphoramidate capsule modification in Campylobacter jejuni.
    McNally DJ; Lamoureux MP; Karlyshev AV; Fiori LM; Li J; Thacker G; Coleman RA; Khieu NH; Wren BW; Brisson JR; Jarrell HC; Szymanski CM
    J Biol Chem; 2007 Sep; 282(39):28566-28576. PubMed ID: 17675288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemical structure and genetic locus of Campylobacter jejuni CG8486 (serotype HS:4) capsular polysaccharide: the identification of 6-deoxy-D-ido-heptopyranose.
    Chen YH; Poly F; Pakulski Z; Guerry P; Monteiro MA
    Carbohydr Res; 2008 May; 343(6):1034-40. PubMed ID: 18346720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni.
    Monteiro MA; Baqar S; Hall ER; Chen YH; Porter CK; Bentzel DE; Applebee L; Guerry P
    Infect Immun; 2009 Mar; 77(3):1128-36. PubMed ID: 19114545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological roles of the O-methyl phosphoramidate capsule modification in Campylobacter jejuni.
    van Alphen LB; Wenzel CQ; Richards MR; Fodor C; Ashmus RA; Stahl M; Karlyshev AV; Wren BW; Stintzi A; Miller WG; Lowary TL; Szymanski CM
    PLoS One; 2014; 9(1):e87051. PubMed ID: 24498018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HS:1 serostrain of Campylobacter jejuni has a complex teichoic acid-like capsular polysaccharide with nonstoichiometric fructofuranose branches and O-methyl phosphoramidate groups.
    McNally DJ; Jarrell HC; Li J; Khieu NH; Vinogradov E; Szymanski CM; Brisson JR
    FEBS J; 2005 Sep; 272(17):4407-22. PubMed ID: 16128810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-surface alpha-glucan in Campylobacter jejuni 81-176.
    Papp-Szabó E; Kanipes MI; Guerry P; Monteiro MA
    Carbohydr Res; 2005 Sep; 340(13):2218-21. PubMed ID: 16055105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase variable expression of capsular polysaccharide modifications allows Campylobacter jejuni to avoid bacteriophage infection in chickens.
    Holst Sørensen MC; van Alphen LB; Fodor C; Crowley SM; Christensen BB; Szymanski CM; Brøndsted L
    Front Cell Infect Microbiol; 2012; 2():11. PubMed ID: 22919603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 6-deoxy-d-ido-heptopyranose-containing fragments of the Campylobacter jejuni strain CG8486 capsular polysaccharide.
    Thota VN; Lowary TL
    Carbohydr Res; 2024 Feb; 536():109058. PubMed ID: 38354653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HS:19 serostrain of Campylobacter jejuni has a hyaluronic acid-type capsular polysaccharide with a nonstoichiometric sorbose branch and O-methyl phosphoramidate group.
    McNally DJ; Jarrell HC; Khieu NH; Li J; Vinogradov E; Whitfield DM; Szymanski CM; Brisson JR
    FEBS J; 2006 Sep; 273(17):3975-89. PubMed ID: 16879613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a Glutamine Kinase Required for the Biosynthesis of the O-Methyl Phosphoramidate Modifications Found in the Capsular Polysaccharides of Campylobacter jejuni.
    Taylor ZW; Brown HA; Narindoshvili T; Wenzel CQ; Szymanski CM; Holden HM; Raushel FM
    J Am Chem Soc; 2017 Jul; 139(28):9463-9466. PubMed ID: 28650156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-specific differences in the response of cultured macrophages to Campylobacter jejuni capsule and O-methyl phosphoramidate mutants.
    Kim S; Vela A; Clohisey SM; Athanasiadou S; Kaiser P; Stevens MP; Vervelde L
    Vet Res; 2018 Jan; 49(1):3. PubMed ID: 29316981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships of capsular polysaccharides belonging to Campylobacter jejuni HS1 serotype complex.
    Monteiro MA; Chen YH; Ma Z; Ewing CP; Mohamad Nor N; Omari E; Song E; Gabryelski P; Guerry P; Poly F
    PLoS One; 2021; 16(2):e0247305. PubMed ID: 33621246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.
    Maue AC; Poly F; Guerry P
    Hum Vaccin Immunother; 2014; 10(6):1499-504. PubMed ID: 24632556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.